Division of Biliopancreas, Department of Surgery, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul, 120-752, Korea.
Surg Endosc. 2011 Jun;25(6):2004-9. doi: 10.1007/s00464-010-1504-1. Epub 2010 Dec 7.
Function-preserving minimally invasive pancreatectomy is thought to be an ideal approach for pancreatic benign and borderline malignant lesions requiring pancreatectomy. However, it is not that easy to accomplish this goal with the conventional laparoscopic approach. It requires extensive surgeon experience and learned techniques. A robot surgical system was recently introduced to overcome these limitations and it may potentially provide precise and safe laparoscopic surgery.
Between March 2006 and July 2010, a total of 45 patients underwent laparoscopic or robot-assisted pancreatectomy performed by a single pancreatic surgeon to preserve the spleen. Twenty-five patients underwent the conventional laparoscopic approach (Lap group) and the other 20 patients underwent robot-assisted surgery (Robot group). The perioperative clinicopathologic variables (age, gender, length of resected pancreas, tumor size, tumor location, amount of bleeding, operation time, length of hospital stay, complications, mortality, and cost) were compared between the two groups, as well as the spleen preservation rate.
Younger patients preferred robot-assisted surgery to conventional laparoscopic surgery (44.5±15.9 vs. 56.7±13.9 years, p=0.010), and the mean operation time was longer in the Robot group (258.2±118.6 vs. 348.7±121.8 min, p=0.016). The spleen-preserving rate of the Robot group was considerably superior to that of the Lap group (fail/success, 9/16 vs. 1/19, p=0.027). However, robot surgery cost the patients about USD 8,300 (USD 8,304.8±870.0), which was more than twice the amount for the Lap group (USD 3,861.7±1,724.3). There were no significant differences in other clinicopathologic variables.
Robot-assisted pancreatic surgery could provide an increased chance for spleen preservation in spite of higher cost and longer operation time. More experiences are needed to specifically address the role of robot surgery in the advanced laparoscopic era.
保留功能的微创胰腺切除术被认为是一种理想的胰腺良性和交界性恶性病变需要胰腺切除术的方法。然而,通过传统的腹腔镜方法实现这一目标并不容易。它需要广泛的外科医生经验和学习技术。机器人手术系统最近被引入,以克服这些限制,它可能提供精确和安全的腹腔镜手术。
在 2006 年 3 月至 2010 年 7 月期间,共有 45 例患者由一位胰腺外科医生进行了腹腔镜或机器人辅助胰腺切除术,以保留脾脏。25 例患者接受了传统腹腔镜手术(Lap 组),另外 20 例患者接受了机器人辅助手术(Robot 组)。比较了两组患者的围手术期临床病理变量(年龄、性别、切除胰腺长度、肿瘤大小、肿瘤位置、出血量、手术时间、住院时间、并发症、死亡率和成本),以及脾保留率。
年轻患者更喜欢机器人辅助手术而不是传统腹腔镜手术(44.5±15.9 岁比 56.7±13.9 岁,p=0.010),Robot 组的平均手术时间也较长(258.2±118.6 分钟比 348.7±121.8 分钟,p=0.016)。Robot 组的脾保留率明显优于 Lap 组(失败/成功,9/16 比 1/19,p=0.027)。然而,机器人手术的费用约为 8300 美元(8304.8±870.0 美元),是 Lap 组的两倍多(3861.7±1724.3 美元)。其他临床病理变量无显著差异。
机器人辅助胰腺手术可以提供更高的脾保留机会,尽管成本更高,手术时间更长。在先进的腹腔镜时代,需要更多的经验来具体确定机器人手术的作用。